pharmaand GmbH
Works in Cardiovascular · Dermatology · GI & liver · Hematology · Immunology · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health
pharmaand GmbH is a clinical trial sponsor. It has 1 active clinical trial with 1,097 planned participants, across 10 therapeutic areas. Since 2021 it has completed 17 trials and stopped 4 early.
Trial track record · since 2021
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about pharmaand GmbH
pharmaand GmbH is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 1,097 planned participants, in Cardiovascular, Dermatology, GI & liver, Hematology and other areas. Since 2021 it has completed 17 trials and stopped 4 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with pharmaand GmbH; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-07-25.
Approve Suite is not affiliated with pharmaand GmbH.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.